The progress in study of fosfomycin
In recent years, heavy drug resistance in bacteria has become increasingly serious, and the progress of research and development of new antibiotics are slow. Therefore, seeking an alternative from the safe and effective “old medicine” is a strategy for clinical action against infection. Among them,...
Main Author: | Jia Yuchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-04-01
|
Series: | Infection International |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/ii.2017.6.issue-3/ii-2017-0162/ii-2017-0162.xml?format=INT |
Similar Items
-
Fosfomycin: Pharmacological, Clinical and Future Perspectives
by: Anneke Corinne Dijkmans, et al.
Published: (2017-10-01) -
Fosfomycin: Uses and potentialities in veterinary medicine
by: D.S. Pérez, et al.
Published: (2014-03-01) -
In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae
by: Wei Yu, et al.
Published: (2017-06-01) -
Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation
by: O. Asuphon, et al.
Published: (2016-09-01) -
Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing <i>K. pneumoniae</i> Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside
by: Alessandra Oliva, et al.
Published: (2021-06-01)